Abstract | BACKGROUND: METHODS: From 2000 to 2003, 21 patients with MPM (14 males and 7 females, median age 59 years) were enrolled in the prospective study. Induction chemotherapy consisted of Carboplatin (AUC 5mg/mL/min on Day 1) and Gemcitabine (1000mg/m(2) on Days 1, 8, 15) for three to four cycles. EPP was performed 3-5 weeks after induction therapy, while post-operative RT was given 4-6 weeks after operation. RESULTS: Ten patients received three cycles of chemotherapy, 10 patients received four cycles and 1 patient had two cycles. Grades 3-4 haematological toxicity occurred in eight (38.1%) patients. Chemotherapy response rate was: complete 0%, partial 33.3% and stable disease 66.7%. Seventeen (80.9%) out of 21 patients underwent EPP with no intra or post-operative mortality with an overall major and minor morbidity rate at 52.4%. Median survival was 25.5 months, with an overall 1, 3 and 5-year survival rate of 71, 33 and 19%, respectively. CONCLUSIONS: In MPM, the combined modality approach using the Carboplatin/ Gemcitabine combination as induction chemotherapy is feasible, with good results in terms of survival and morbidity. Our results are similar to those of other studies using a heavier modality treatment.
|
Authors | Federico Rea, Giuseppe Marulli, Luigi Bortolotti, Cristiano Breda, Adolfo Gino Favaretto, Lucio Loreggian, Francesco Sartori |
Journal | Lung cancer (Amsterdam, Netherlands)
(Lung Cancer)
Vol. 57
Issue 1
Pg. 89-95
(Jul 2007)
ISSN: 0169-5002 [Print] Ireland |
PMID | 17403553
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Antimetabolites, Antineoplastic
- Antineoplastic Agents
- Deoxycytidine
- Carboplatin
- Gemcitabine
|
Topics |
- Adult
- Aged
- Anemia
(chemically induced)
- Antimetabolites, Antineoplastic
(administration & dosage, toxicity)
- Antineoplastic Agents
(administration & dosage, toxicity)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, toxicity)
- Carboplatin
(administration & dosage, toxicity)
- Combined Modality Therapy
- Deoxycytidine
(administration & dosage, analogs & derivatives, toxicity)
- Drug Administration Schedule
- Feasibility Studies
- Female
- Follow-Up Studies
- Humans
- Leukopenia
(chemically induced)
- Male
- Mesothelioma
(drug therapy, pathology, radiotherapy, surgery)
- Middle Aged
- Neoplasm Recurrence, Local
(pathology)
- Neoplasm Staging
- Neutropenia
(chemically induced)
- Pleural Neoplasms
(drug therapy, pathology, radiotherapy, surgery)
- Pneumonectomy
(statistics & numerical data)
- Radiation Dosage
- Radiotherapy, Adjuvant
- Survival Analysis
- Thrombocytopenia
(chemically induced)
- Time Factors
- Gemcitabine
|